Skip to main content

Table 1 Demographics, hepatitis C genotype, and non-invasive fibrosis assessment among Georgian prisoners with chronic hepatitis C infection, December 2013–April 2015

From: An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia’s corrections system, December 2013 – April 2015

  Among prisoners receiving a full diagnostic evaluation %
N 880  
Median age (years) 40 (Range: 18–71)  
Male (years) 40 (Range: 18–71)  
Female (years) 43 (Range: 25–54)  
Sex
 Male 858 97.5%
 Female 22 2.5%
HCV Genotype
 1 200 22.7%
 2 253 28.8%
 3 420 47.7%
 Mixed 1 & 2 5 0.6%
 Mixed 1 & 3 1 0.1%
 6 1 0.1%
Non-Invasive Fibrosis Staging
 6.5 kPa – < 8.0 kPa (Metavir F2) 406 46.1%
 8.0 kPa – < 10 kPa (Metavir F2-F3) 192 21.8%
 10 kPa – < 12.5 kPa (Metavir F3) 127 14.4%
 12.5 kPa – < 14 kPa (Metavir F3-F4) 23 2.6%
  ≥ 14 kPa (Metavir F4) 132 15.0%
FIB-4
  < 1.45 573 65.1%
 1.45–3.25 255 29.0%
  > 3.25 52 5.9%
APRI
  < 1.0 651 74.0%
 1.0–2.0 167 19.0%
  > 2.0 62 7.0%